Additionally, Nutlin-3 can act as an immune adjuvant by inducing the expression of HLA-I and HLA-DR in tumors through the CIITA, thereby augmenting the anti-tumor properties of T cells [97]. This evidence concerns the gene CIITA and neoplasm.